Abstract
Natural products are a class of chemical compounds that are biosynthesized by living organisms, including humans. Endogenous natural products are produced by human cells as well as by the human microbiome. This contribution describes the current understanding and recent progress made on endogenous natural products that are produced by human cells, including amines, steroids, and fatty acid-derived natural products. The co-metabolism and natural product produced by the human microbiome will also be described, including the involvement of tryptophan, bile acids, choline, and cysteine. New strategies and technologies have been introduced that can be applied to identify and characterize those natural products produced by the human microbiome in terms of their composition and physiological function.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI (2007) The human microbiome project. Nature 449:804
Ng J, Papandreou A, Heales SJ, Kurian MA (2015) Monoamine neurotransmitter disorders—clinical advances and future perspectives. Nat Rev Neurol 11:567
Eisenhofer G, Kopin IJ, Goldstein DS (2004) Catecholamine metabolism: a contemporary view with implications for physiology and medicine. Pharmacol Rev 56:331
Gainetdinov RR, Hoener MC, Berry MD, Witkin JM (2018) Trace amines and their receptors. Pharm Rev 70:549
Miller WL, Auchus RJ (2011) The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev 32:81
Xiao X, Tang J-J, Peng C, Wang Y, Fu L, Qiu Z-P, Xiong Y, Yang L-F, Cui H-W, He X-L, Yin L, Qi W, Wong CCL, Zhao Y, Li B-L, Qiu W-W, Song BL (2017) Cholesterol modification of smoothened is required for hedgehog signaling. Mol Cell 66:154
Folco G, Murphy RC (2006) Eicosanoid transcellular biosynthesis: from cell-cell interactions to in vivo tissue responses. Pharmacol Rev 58:375
Calder PC (2015) Marine omega-3 fatty acids and inflammatory processes: effects, mechanisms and clinical relevance. Biochim Biophys Acta 1851:469
Venable ME, Zimmerman GA, McIntyre TM, Prescott SM (1993) Platelet-activating factor: a phospholipid autacoid with diverse actions. J Lipid Res 34:691
Ryan SD, Harris CS, Mo F, Lee H, Hou ST, Bazan NG, Haddad PS, Arnason JT, Bennett SAL (2007) Platelet activating factor-induced neuronal apoptosis is initiated independently of its G-protein coupled PAF receptor and is inhibited by the benzoate orsellinic acid. J Neurochem 103:88
The Human Microbiome Project Consortium (2012) Structure, function and diversity of the healthy human microbiome. Nature 486:207
Lloyd-Price J, Mahurkar A, Rahnavard G, Crabtree J, Orvis J, Hall AB, Brady A, Creasy HH, McCracken C, Giglio MG, McDonals D, Franzosa EA, Knight R, White O, Huttenhower C (2017) Strains, functions and dynamics in the expanded human microbiome project. Nature 550:61
Rath CM, Dorrestein PC (2012) The bacterial chemical repertoire mediates metabolic exchange within gut microbiomes. Curr Opin Microbiol 15:147
Kim CH (2018) Immune regulation by microbiome metabolites. Immunology 154:220
Blacher E, Levy M, Tatirovsky E, Elinav E (2017) Microbiome-modulated metabolites at the interface of host immunity. J Immunol 198:572
Tombari RJ, Saunders CM, Wu C-Y, Dunlap LE, Tantillo DJ, Olson DE (2019) Ex vivo analysis of tryptophan metabolism using 19F NMR. ACS Chem Biol 14:1866
Dodd D, Spitzer MH, Van Treuren W, Merrill BD, Hryckowian AJ, Higginbottom SK, Le A, Cowan TM, Nolan GP, Fischbach MA, Sonnenburg JL (2017) A gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolites. Nature 55:648
Thomas C, Pellicciari R, Pruzanski M, Auwerx J, Schoonjans K (2008) Targeting bile-acid signalling for metabolic diseases. Nat Rev Drug Discov 7:678
Yu H, Zhao T, Liu S, Wu Q, Johnson O, Wu Z, Zhuang Z, Shi Y, Peng L, He R, Yang Y, Sun J, Wang X, Xu H, Zheng Z, Zou P, Lei X, Luo W, Li Y (2019) MRGPRX4 is a bile acid receptor for human cholestatic itch. eLife 8:e48431
Lee SP, Lester R, Pyrek JS (1987) Vulpecholic acid (1α,3α,7α-trihydroxy-5β-cholan-24-oic acid): a novel bile acid of a marsupial, Trichosurus vulpecula (Lesson). J Lipid Res 28:19
Roda A, Grigolo B, Minutello A, Pellicciari R, Natalini B (1990) Physicochemical and biological properties of natural and synthetic C-22 and C-23 hydroxylated bile acids. J Lipid Res 31:289
Hylemon PB, Melone PD, Franklund CV, Lund E, Björkhem I (1991) Mechanism of intestinal 7α-dehydroxylation of cholic acid: evidence that allo-deoxycholic acid is an inducible side-product. J Lipid Res 32:89
Craciun S, Balskus EP (2012) Microbial conversion of choline to trimethylamine requires a glycyl radical enzyme. Proc Natl Acad Sci USA 109:21307
Wang Z, Roberts AB, Buffa JA, Levison BF, Zhu W, Org E, Gu X, Huang Y, Zamanian-Daryoush M, Culley MK, DiDonato AJ, Fu X, Hazen JE, Krajcik D, DiDonato JA, Lusis AJ, Hazen SL (2015) Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis. Cell 163:1585
Dorrestein PC, Mazmanian SK, Knight R (2014) From microbiomess to metabolomes to function during host-microbial interactions. Immunity 40:824
Dettmer K, Aronov PA, Hammock BD (2007) Mass spectrometry-based metabolomics. Mass Spectrom Rev 26:51
Dunn WB, Broadhurst DI, Atherton HJ, Goodacre R, Griffin JL (2011) Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy. Chem Soc Rev 40:387
Theodoridis GA, Gika HG, Want EJ, Wilson ID (2012) Liquid chromatography–mass spectrometry based global metabolite profiling: a review. Anal Chim Acta 711:7
Dettmer K, Aronov PA, Hammock BD (2007) Mass spectrometry-based metabolomics. Mass Spectrom Rev 26:51
Lu W, Bennett BD, Rabinowitz JD (2008) Analytical strategies for LC-MS-based targeted metabolomics. J Chromatogr, B: Anal Technol Biomed Life Sci 871:236
Gika HG, Theodoridis GA, Plumb RS, Wilson ID (2014) Current practice of liquid chromatography–mass spectrometry in metabolomics and metabonomics. J Pharm Biomed An 87:12
Chew WS, Torta F, Ji S, Choi H, Begum H, Sim X, Khoo CM, Khoo EYH, Ong W-Y, Van Dam RM, Wenk MR, Tai ES, Herr DR (2019) Large-scale lipidomics identifies associations between plasma sphingolipids and T2DM incidence. JCI Insight 5:e126925
Shah SH, Kraus WE, Newgard CB (2012) Metabolomic profiling for the identification of novel biomarkers and mechanisms related to common cardiovascular diseases: form and function. Circulation 126:1110
Markley JL, Bruschweiler R, Edison AS, Eghbalnia HR, Powers R, Raftery D, Wishart DS (2017) The future of NMR-based metabolomics. Curr Opin Biotechnol 43:34
Larive CK, Barding G Jr, Dinges MM (2015) NMR spectroscopy for metabolomics and metabolic profiling. Anal Chem 87:133
Acknowledgements
Financial support from the National Natural Science Foundation of China Grant (21625201, 21961142010, 21661140001, 91853202, and 21521003), the National Key Research and Development Program of China (2017YFA0505200), the Beijing Outstanding Young Scientist Program (BJJWZYJH01201910001001) is gratefully acknowledged.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Bai, Y., Zhang, L., Lei, X. (2021). Human Endogenous Natural Products. In: Kinghorn, A.D., Falk, H., Gibbons, S., Kobayashi, J., Asakawa, Y., Liu, JK. (eds) Progress in the Chemistry of Organic Natural Products 114. Progress in the Chemistry of Organic Natural Products, vol 114. Springer, Cham. https://doi.org/10.1007/978-3-030-59444-2_4
Download citation
DOI: https://doi.org/10.1007/978-3-030-59444-2_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-59443-5
Online ISBN: 978-3-030-59444-2
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)